ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma

Figure 3

The disease-free survival (RFS) analysis for LPCAT1 in various human cancers determined by the GEPIA database. (a)–(l) The OS plot of LPCAT1 in BLCA (a), BRCA (b), CHOL (c), COAD (d), ESCA (e), GBM (f), HNSC (g), KICH (h), KIRC (i), KIRP (j), LIHC (k), LUAD (l), LUSC (m), PRAD (n), READ (o), STAD (p), THCA (q), and UCEC (r).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)

(q)

(r)